{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:44:44Z","timestamp":1790675084646,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T00:00:00Z","timestamp":1424476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Reumatologia"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.rbr.2014.12.011","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T01:15:17Z","timestamp":1425431717000},"page":"287-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sobreposi\u00e7\u00e3o de esclerose sist\u00eamica e artrite reumatoide: uma entidade cl\u00ednica distinta?"],"prefix":"10.1186","volume":"56","author":[{"given":"Alex Magno Coelho","family":"Horimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaias Pereira da","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"3","key":"10.1016\/j.rbr.2014.12.011_bib0250","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.rbr.2014.12.011_bib0255","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/ar402","article-title":"Genetic epidemiology Systemic sclerosis","volume":"4","author":"Herrick","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.rbr.2014.12.011_bib0260","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10067-009-1144-9","article-title":"Systemic sclerosis: a world wide global analysis","volume":"28","author":"Coral-Alvarado","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/ar2598","article-title":"Hypoxia in the pathogenesis of systemic sclerosis","volume":"11","author":"Beyer","year":"2009","journal-title":"Arthritis Res. Ther"},{"key":"10.1016\/j.rbr.2014.12.011_bib0270","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.semarthrit.2011.10.003","article-title":"Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis","volume":"41","author":"Clements","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rbr.2014.12.011_bib0275","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/34.9.831","article-title":"Arthritis in scleroderma","volume":"34","author":"Misra","year":"1995","journal-title":"British J Rheumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0280","first-page":"101","article-title":"The arthropathy of systemic sclerosis (scleroderma); comparison with mixed connective tissue disease","volume":"1","author":"Catoggio","year":"1983","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0285","first-page":"81","article-title":"The rheumatic manifestations of progressive systemic sclerosis (scleroderma)","volume":"57","author":"Rodnan","year":"1968","journal-title":"Clin Orthop Rel Res"},{"key":"10.1016\/j.rbr.2014.12.011_bib0290","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2458-7-260","article-title":"Erosive arthropathy in systemic sclerosis","volume":"7","author":"Allali","year":"2007","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.rbr.2014.12.011_bib0295","first-page":"65","article-title":"Manifesta\u00e7\u00f5es osteoarticulares na esclerose sist\u00eamica","volume":"28","author":"Fernandes","year":"1988","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2011.09.010","article-title":"Arthritis in patients with systemic sclerosis","volume":"23","author":"Schmeiser","year":"2012","journal-title":"Europ J Intern Med"},{"key":"10.1016\/j.rbr.2014.12.011_bib0305","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/kem021","article-title":"Systemic sclerosis\u2010rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity","volume":"46","author":"Sz\u00fccs","year":"2007","journal-title":"Rheumatology"},{"issue":"65","key":"10.1016\/j.rbr.2014.12.011_bib0310","first-page":"S6","article-title":"Association study of 3 rheumatoid arthritis risk loci in systemic sclerosis in a European caucasian population","volume":"29","author":"Coustet","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0315","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rhematology\/European league against rheumatism collaborative initiative","volume":"72","author":"Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rbr.2014.12.011_bib0320","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.rbr.2014.12.011_bib0325","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria. An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbr.2014.12.011_bib0330","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.62.9.904","article-title":"European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score","volume":"62","author":"Valentini","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbr.2014.12.011_bib0335","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","article-title":"Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well\u2010being","volume":"29","author":"Medsger","year":"2003","journal-title":"Rheum Dis Clin N Am"},{"issue":"S29","key":"10.1016\/j.rbr.2014.12.011_bib0340","first-page":"S39","article-title":"Assessment of disease activity","volume":"21","author":"Valentini","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rbr.2014.12.011_bib0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/art.22468","article-title":"Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin hand function scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36\u2010item short form health survey","volume":"57","author":"Rannou","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rbr.2014.12.011_bib0350","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0482-50042003000300002","article-title":"II Consenso Brasileiro de Fator Antinuclear em c\u00e9lulas Hep\u20102","volume":"43","author":"Dellavance","year":"2003","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0355","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4049\/jimmunol.168.4.2054","article-title":"Anti\u2010Sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens","volume":"168","author":"McClain","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0360","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/rheumatology\/40.10.1135","article-title":"Clinical significance of anti\u2010topoisomerase I antibody levels determined by Elisa in systemic sclerosis","volume":"40","author":"Sato","year":"2001","journal-title":"Rheum"},{"key":"10.1016\/j.rbr.2014.12.011_bib0365","first-page":"373","article-title":"Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis","volume":"25","author":"Codullo","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0370","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/rheumatology\/kei248","article-title":"Successful treatment with leflunomide of arthritis in systemic sclerosis patients","volume":"45","author":"Sebastiani","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.rbr.2014.12.011_bib0375","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3899\/jrheum.111582","article-title":"Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients","volume":"39","author":"Sampaio-Barros","year":"2012","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.rbr.2014.12.011_bib0380","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1590\/S0365-05962011000600003","article-title":"Autoanticorpos em esclerodermia e sua associa\u00e7\u00e3o ao perfil cl\u00ednico da doen\u00e7a. Estudo em 66 pacientes do sul do Brasil","volume":"86","author":"Skare","year":"2011","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.rbr.2014.12.011_bib0385","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1590\/S1806-37132005000400006","article-title":"Comprometimento do interst\u00edcio pulmonar em portadores de esclerose sist\u00eamica progressiva. Estudo de uma s\u00e9rie de 58 casos","volume":"31","author":"Jezler","year":"2005","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0390","first-page":"367","article-title":"Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis \u2013 measuring functional impairment in systemic sclerosis versus other connective tissue diseases","volume":"25","author":"Morita","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"S11","key":"10.1016\/j.rbr.2014.12.011_bib0395","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/acr.20598","article-title":"Measures of systemic sclerosis (Scleroderma)","volume":"63","author":"Pope","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.rbr.2014.12.011_bib0400","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbr.2014.12.011_bib0405","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10067-004-0942-3","article-title":"Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)","volume":"24","author":"Georges","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10067-004-0970-z","article-title":"Health\u2010related quality of life measured by the Short Form 36 (SF\u201036) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms","volume":"24","author":"Danieli","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0415","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaut.2008.05.002","article-title":"Polyautoimmunity and familial autoimmunity in systemic sclerosis","volume":"31","author":"Hudson","year":"2008","journal-title":"J Autoimm"},{"issue":"1","key":"10.1016\/j.rbr.2014.12.011_bib0420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.rdc.2007.10.001","article-title":"Genetics and genomic studies in scleroderma (systemic sclerosis)","volume":"34","author":"Agarwal","year":"2008","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.rbr.2014.12.011_bib0425","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3899\/jrheum.111104","article-title":"Familial autoimmunity in systemic sclerosis \u2013 results of a french\u2010based case\u2010control family study","volume":"39","author":"Koumakis","year":"2012","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.rbr.2014.12.011_bib0430","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/art.24328","article-title":"Familial associations of rheumatoid arthritis with autoimune diseases and related conditions","volume":"60","author":"Hemminki","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbr.2014.12.011_bib0435","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/319518","article-title":"A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimune diseases","volume":"68","author":"Jawaheer","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rbr.2014.12.011_bib0440","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00296-006-0207-3","article-title":"Coexistence of systemic sclerosis with other autoimune diseases","volume":"27","author":"Caramaschi","year":"2007","journal-title":"Rheumatol Int"},{"issue":"17","key":"10.1016\/j.rbr.2014.12.011_bib0445","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/1381612003398690","article-title":"Current problems with non\u2010specific COX inhibitors","volume":"6","author":"McGettigan","year":"2000","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.rbr.2014.12.011_bib0450","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1532-5415.1984.tb02007.x","article-title":"Problems of antiarthritic therapy in the elderly","volume":"32","author":"Brooks","year":"1984","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.rbr.2014.12.011_bib0455","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","article-title":"Experience with rituximab in scleroderma: results from a 1\u2010year, proof\u2010of\u2010principle study","volume":"49","author":"Daoussis","year":"2010","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rbr.2014.12.011_bib0460","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.24249","article-title":"B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis","volume":"60","author":"Lafyatis","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbr.2014.12.011_bib0465","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.2008.095463","article-title":"Rituximab in diffuse cutaneous systemic sclerosis: an open\u2010label clinical and histopathological study","volume":"69","author":"Smith","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbr.2014.12.011_bib0470","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3899\/jrheum.100361","article-title":"Biologic therapy for systemic sclerosis: a systematic review","volume":"38","author":"Phumethum","year":"2011","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.rbr.2014.12.011_bib0475","doi-asserted-by":"crossref","first-page":"918","DOI":"10.7326\/0003-4819-143-12-200512200-00019","article-title":"Tumor necrosis fator\u2010\u03b1 inhibitor therapy in erosive polyarthritis secundary to systemic sclerosis","volume":"143","author":"Bosello","year":"2005","journal-title":"Ann Intern Med"},{"issue":"71","key":"10.1016\/j.rbr.2014.12.011_bib0480","first-page":"S55","article-title":"Long\u2010term safety and effectiveness of tumour necrosis fator inhibitors in systemic sclerosis patients with inflammatory arthritis","volume":"30","author":"Omair","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"65","key":"10.1016\/j.rbr.2014.12.011_bib0485","first-page":"S40","article-title":"Is there a role for TNF\u2010\u03b1 antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique","volume":"29","author":"Distler","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rbr.2014.12.011_bib0490","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/annrheumdis-2012-202657","article-title":"Outcomes of patients with systemic sclerosis\u2010associated polyarthritis and myopathy treated with tocilizumab or abatacept: a Eusar observational study","volume":"72","author":"Elhai","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Revista Brasileira de Reumatologia"],"original-title":[],"language":"pt","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0482500415000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0482500415000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T13:20:25Z","timestamp":1514899225000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0482500415000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0482500415000303"],"URL":"https:\/\/doi.org\/10.1016\/j.rbr.2014.12.011","relation":{},"ISSN":["0482-5004"],"issn-type":[{"value":"0482-5004","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sobreposi\u00e7\u00e3o de esclerose sist\u00eamica e artrite reumatoide: uma entidade cl\u00ednica distinta?","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Reumatologia","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.rbr.2014.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}